🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524206-15-00
Completed Phase I

A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity

2025-524206-15-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
02/04/2026
Enrollment target
120
Sites
Germany

Condition studied

Obesity

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524206-15-00 on CTIS ↗ ← All trials in the EU